JournalsHub
.online
Find My Journal
FA

Francis P. Arena

Independent Researcher

ORCID 0000-0002-7215-2551
76
Publications
9,057
Citations
23
H-Index
30
i10-Index
8.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante +18 more
New England Journal of Medicine 2013
6,569
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis OA
Denise A. Yardley, Shinzaburo Noguchi, Kathleen I. Pritchard, Howard A. Burris, José Baselga +15 more
Advances in Therapy 2013
514
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
Fabrice André, Ruth O’Regan, Mustafa Özgüroğlu, Masakazu Toi, Binghe Xu +18 more
The Lancet Oncology 2014
491
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer OA
Denise A. Yardley, Robert Weaver, Michelle Melisko, Mansoor N. Saleh, Francis P. Arena +15 more
Journal of Clinical Oncology 2015
185
Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer
Massimo Cristofanilli, Vicente Valero, Aroop Mangalik, Melanie Royce, Ian Rabinowitz +8 more
Clinical Cancer Research 2010
159

Publications

75 total

Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study OA

A. Lasagna, F. Bergami, D. Lilleri, E. Percivalle, M. Quaccini - ESMO Open, 2022
Cited by 21 Semantic Scholar

Critical Aspects of a Sustainable Clinical Research Program in the Community-Based Oncology Practice.

Jennifer L. Ersek, S. Graff, F. Arena, N. Denduluri, Edward S. Kim - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2019
Cited by 6 Semantic Scholar

A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer PDF

Lee S. Schwartzberg, Francis P. Arena, Bryan Bienvenu, Edward H. Kaplan, Luis H. Camacho et al. - Journal of Cancer, 2017
Cited by 47 OpenAlex

A Continuum of Hereditary Cardiac Disease

S. Ruben, J. Christodoulou, F. Arena, L. Arditi, S. Scheidt - Unknown Venue, 2017
Cited by 0 Semantic Scholar

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer PDF

E. Gabriela Chiorean, Daniel D. Von Hoff, Michele Reni, Francis P. Arena, Jeffrey R. Infante et al. - Annals of Oncology, 2016
Cited by 101 OpenAlex

Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas PDF

Ramesh K. Ramanathan, David Goldstein, Ron Korn, Francis P. Arena, Malcolm J. Moore et al. - Annals of Oncology, 2016
Cited by 42 OpenAlex

CA 19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial ( MPACT ) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer

Gabi Chiorean, V. Bathini, Venu G And Bathini, E. Chiorean, D. D. Hoff - Unknown Venue, 2016
Cited by 11 Semantic Scholar

Abstract P4-13-12: Everolimus plus trastuzumab and vinorelbine for trastuzumab-resistant, taxane-pretreated, HER2+ advanced breast cancer: Overall survival results from BOLERO-3

C. Isaacs, R. O'Regan, Bing-he Xu, N. Masuda, F. Arena - Unknown Venue, 2016
Cited by 3 Semantic Scholar

Regorafenib for previously treated metastatic colorectal cancer (mCRC): A subgroup analysis of 364 patients in the USA treated in the international, open-label phase IIIb CONSIGN study.

U. Verma, Y. Arriaga, H. Lenz, C. Henderson, J. Fuloria - Unknown Venue, 2016
Cited by 2 Semantic Scholar

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer PDF

Denise A. Yardley, Robert Weaver, Michelle Melisko, Mansoor N. Saleh, Francis P. Arena et al. - Journal of Clinical Oncology, 2015
Cited by 185 OpenAlex

Research Topics

Cancer Treatment and Pharmacology (22) Advanced Breast Cancer Therapies (16) Pancreatic and Hepatic Oncology Research (13) HER2/EGFR in Cancer Research (12) Colorectal Cancer Treatments and Studies (10)

Frequent Co-Authors

DA
Daniel D. Von Hoff
5 joint publications
RA
Ramesh K. Ramanathan
5 joint publications
JO
Josep Tabernero
5 joint publications
E.
E. Gabriela Chiorean
4 joint publications
JE
Jeffrey R. Infante
4 joint publications
MA
Malcolm J. Moore
4 joint publications

Affiliations

Memorial Sloan Kettering Cancer Center
US 1981 - 1980
NewYork–Presbyterian Hospital
US 1980 - 1980
The University of Texas MD Anderson Cancer Center
US 2010 - 2010
University of New Mexico
US 2010 - 2010
Chinese Academy of Medical Sciences & Peking Union Medical College
CN 2016 - 2016

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now